This interactive case-based CME program is designed for clinicians who seek to enhance and optimize their knowledge and clinical skills in identifying, risk-stratifying, and managing hyperlipidemia to reduce atherosclerotic cardiovascular disease (ASCVD) risk. The program combines didactic evidence, clinical pearls, and real-world case presentations to explore lipid pathophysiology, primary and secondary preventions, lifestyle intervention, and both statin and non-statin therapy options. Emphasis will be placed on individual risk assessment, shared medical decision-making, and practical tools for implementing treatment plans in diverse patient populations. Clinicians will gain the knowledge and confidence in implementing guideline-directed and evidence-based treatment plans that include both statin and non-statin lipid-lowering therapies.

Metabolic dysfunction-associated steatotic liver disease (MASLD), previously known as NAFLD, is now the most common chronic liver disease worldwide and a rising cause of cirrhosis and liver-related mortality. Primary care providers are at the forefront of identifying patients at risk. Yet recognition, staging, and management remain inconsistent. This dynamic session will equip clinicians with the tools to understand the new terminology and diagnostic criteria for MASLD and metabolic dysfunction-associated steatohepatitis (MASH) and incorporate simple, evidence-based risk stratification strategies (including FIB-4 and non-invasive fibrosis assessments) into routine practice. Clinicians will navigate the application of lifestyle and pharmacologic interventions to slow progression and reduce metabolic risk, while recognizing when to refer to hepatology. By the end of the session, participants will feel confident screening, counseling, and coordinating care for patients with MASLD/MASH in the primary care setting.

Hyperthyroidism presents unique diagnostic and management challenges in the primary care setting. This CME session will guide clinicians through recognizing the signs and symptoms of hyperthyroidism, categorizing common causes, and applying appropriate screening and diagnostic strategies to facilitate accurate diagnosis through judicious testing strategies. Participants will also analyze treatment options tailored to underlying etiology while incorporating shared medical decision-making to optimize patient outcomes. Throughout this dynamic case-based program, we will incorporate clinical pearls and common mistakes in identifying, diagnosing, treating, and monitoring thyroid disease.

People with diabetes should receive comprehensive care with an interprofessional team. This course discusses taking a person-centered approach to care that involves a relationship between provider and the person with diabetes in treatment management. It reviews the comprehensive medical evaluation and assessment of comorbidities for the individualized person.

There are so many options for medication management with type 2 diabetes, and it’s imperative to take a person-centered approach when selecting it. This course reviews non-insulin medication and initiating and intensifying insulin therapy to meet the needs of the person living with diabetes.

Technology has changed our world, including how we manage people living with diabetes. This course discusses multiple technological advancements for diabetes, including CGM and insulin delivery devices. It also examines downloading and interpreting AGP reports to help the provider to implement shared decision making into their practice.